Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhuhai Yibang Pharmaceutical is a private Chinese pharmaceutical manufacturer based in Zhuhai, Guangdong, focused on the development, production, and commercialization of chemical drug products and related formulations. Public business-registration sources describe it as an active drug-manufacturing company with R&D activities in pharmaceutical and biochemistry products, and patent records show work on injectable and oral formulations including voriconazole and other small-molecule products. Third-party pipeline databases also associate the company with apapenem, an anti-infective beta-lactam candidate, indicating a business centered on anti-infective small molecules rather than novel biologics. The company appears to operate primarily as a domestic pharma manufacturer with formulation and process-development capabilities, rather than as a platform biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhuhai Yibang Pharmaceutical.